Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid TumorsJulius Strauss, James L. Gulley, Elizabeth Lamping et al.|Clinical Cancer Research|2018Cited by 415
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate CancerJames L. Gulley, William L. Dahut, Seth M. Steinberg et al.|Clinical Cancer Research|2005Cited by 371
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, William L. Dahut, E. Hitt Nichols et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 312